[go: up one dir, main page]

DK1746101T4 - Fremgangsmåde til fremstilling af 3-oxo-pregn-4-en-21,17-carbolactoner ved metalfri oxidation af 17-(3-hydroxypropyl)-3,17-dihydroxyandrostaner - Google Patents

Fremgangsmåde til fremstilling af 3-oxo-pregn-4-en-21,17-carbolactoner ved metalfri oxidation af 17-(3-hydroxypropyl)-3,17-dihydroxyandrostaner

Info

Publication number
DK1746101T4
DK1746101T4 DK05090214.7T DK05090214T DK1746101T4 DK 1746101 T4 DK1746101 T4 DK 1746101T4 DK 05090214 T DK05090214 T DK 05090214T DK 1746101 T4 DK1746101 T4 DK 1746101T4
Authority
DK
Denmark
Prior art keywords
dihydroxyandrostanes
carbolactones
pregn
ene
oxo
Prior art date
Application number
DK05090214.7T
Other languages
English (en)
Other versions
DK1746101T3 (da
Inventor
Carsten Seilz
Hartmut Seba
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35744678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1746101(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Application granted granted Critical
Publication of DK1746101T3 publication Critical patent/DK1746101T3/da
Publication of DK1746101T4 publication Critical patent/DK1746101T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK05090214.7T 2005-07-21 2005-07-21 Fremgangsmåde til fremstilling af 3-oxo-pregn-4-en-21,17-carbolactoner ved metalfri oxidation af 17-(3-hydroxypropyl)-3,17-dihydroxyandrostaner DK1746101T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05090214.7A EP1746101B2 (de) 2005-07-21 2005-07-21 Verfahren zur Herstellung von 3-Oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie Oxidation von 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanen

Publications (2)

Publication Number Publication Date
DK1746101T3 DK1746101T3 (da) 2008-11-24
DK1746101T4 true DK1746101T4 (da) 2014-08-11

Family

ID=35744678

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05090214.7T DK1746101T4 (da) 2005-07-21 2005-07-21 Fremgangsmåde til fremstilling af 3-oxo-pregn-4-en-21,17-carbolactoner ved metalfri oxidation af 17-(3-hydroxypropyl)-3,17-dihydroxyandrostaner

Country Status (22)

Country Link
US (2) US20070049747A1 (da)
EP (1) EP1746101B2 (da)
JP (2) JP5345843B2 (da)
CN (1) CN101223186B (da)
AR (1) AR055993A1 (da)
AT (1) ATE403668T1 (da)
CY (1) CY1110411T1 (da)
DE (1) DE502005004948D1 (da)
DK (1) DK1746101T4 (da)
DO (1) DOP2006000172A (da)
ES (1) ES2311927T5 (da)
GT (1) GT200600321A (da)
MY (1) MY147795A (da)
PE (2) PE20070215A1 (da)
PL (1) PL1746101T5 (da)
PT (1) PT1746101E (da)
SI (1) SI1746101T2 (da)
SV (1) SV2007002621A (da)
TW (1) TWI392683B (da)
UA (1) UA100092C2 (da)
UY (1) UY29686A1 (da)
ZA (1) ZA200801674B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE502005004948D1 (de) * 2005-07-21 2008-09-18 Bayer Schering Pharma Ag Verfahren zur Herstellung von 3-Oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie Oxidation von 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanen
WO2009111574A2 (en) * 2008-03-05 2009-09-11 Evestra, Inc. BISMETHYLENE-17α CARBOLACTONES AND RELATED USES
DE102008026793A1 (de) * 2008-06-02 2009-12-03 Bayer Schering Pharma Aktiengesellschaft C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
WO2010068500A2 (en) * 2008-11-25 2010-06-17 Evestra, Inc. PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES
US8334375B2 (en) * 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone
ES2432063T3 (es) 2009-06-16 2013-11-29 Crystal Pharma, S.A.U. Procedimiento para la obtención de 17-espirolactonas en esteroides
CN101775057B (zh) * 2010-02-09 2014-07-16 浙江仙琚制药股份有限公司 屈螺酮及其中间体的制备方法
CN101830959B (zh) * 2010-05-27 2012-07-18 杭州龙山化工有限公司 一种曲螺酮的合成方法
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
WO2012107513A1 (en) 2011-02-10 2012-08-16 Crystal Pharma, S.A.U. Process for obtaining drospirenone
CN102746370A (zh) * 2011-04-22 2012-10-24 天津金耀集团有限公司 一种氧化合成孕甾11位酮基的新工艺
AU2012365511B2 (en) * 2012-01-13 2016-07-14 Saint-Gobain Glass France Spacer for insulating glazing units
CN102887934B (zh) * 2012-09-20 2015-05-27 杭州福斯特药业有限公司 一种屈螺酮的制备方法
HUE032858T2 (en) * 2013-04-12 2017-11-28 Ind Chimica Srl Method for producing drospirenone
CN104163846A (zh) * 2013-05-17 2014-11-26 上海创诺制药有限公司 一种制备曲螺酮的方法
US10167665B2 (en) 2013-12-12 2019-01-01 Saint-Gobain Glass France Spacer for insulating glazing units, comprising extruded profiled seal
US10190359B2 (en) 2013-12-12 2019-01-29 Saint-Gobain Glass France Double glazing having improved sealing
CN104788524B (zh) * 2014-01-16 2016-07-06 浙江仙居君业药业有限公司 一种19-去甲-4-雄甾烯-3,17-二酮的制备方法
TR201815606T4 (tr) 2014-06-27 2018-11-21 Saint Gobain Mesafe parçasına sahip yalıtım cam kaplaması ve bunun imal edilmesi için yöntem ve ayrıca bunun bina cam kaplaması olarak kullanımı.
WO2015197491A1 (de) 2014-06-27 2015-12-30 Saint-Gobain Glass France Isolierverglasung mit abstandhalter und verfahren zur herstellung
US10626663B2 (en) 2014-09-25 2020-04-21 Saint-Gobain Glass France Spacer for insulating glazing units
DK3265636T3 (da) 2015-03-02 2022-05-23 Saint Gobain Glasfiberforstærket afstandsholder til isoleringsrude, fremgangsmåde til fremstilling af denne og anvendelse af en sådan afstandsholder i flerlagsruder
EP3108889A1 (en) 2015-06-23 2016-12-28 Philippe Perrin Drospirenone-based contraceptive for a female patient affected with excess weight
LT3313408T (lt) 2015-06-23 2024-03-12 Laboratorios Leon Farma Sa Kontraceptikas drospirenono pagrindu, skirtas pacientėms, turinčioms antsvorio

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069219A (en) 1976-12-27 1978-01-17 G. D. Searle & Co. 7ξ-(Alkoxycarbonyl)-6ξ-alkyl/halo-17-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and corresponding 21-carboxylic acids, their salts, and esters
DE3026783C2 (de) 1980-07-11 1982-07-29 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 5β-Hydroxy-δ↑6↑-steroiden
DE3042136A1 (de) 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
ATE15206T1 (de) 1981-09-21 1985-09-15 Schering Ag 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-1 - one, ihre 3,15-trimethylessigsaeure-ester und ihre herstellung.
US5106995A (en) 1989-05-05 1992-04-21 Isp Investments Inc. Production of lactones from diols
DE3916112A1 (de) * 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE19633685C1 (de) * 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
EP1534732B1 (en) * 2002-08-16 2006-09-13 Pharmacia & Upjohn Company LLC 5 androsten-3-ol steroid intermediates and processes for their preparation
JP2005027184A (ja) * 2003-07-04 2005-01-27 Seiko Epson Corp 高周波複合部品
ITMI20040367A1 (it) 2004-03-01 2004-06-01 Ind Chimica Srl Processo per la preparazione di drospirenone
ITMI20042338A1 (it) * 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
DE502005004948D1 (de) * 2005-07-21 2008-09-18 Bayer Schering Pharma Ag Verfahren zur Herstellung von 3-Oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie Oxidation von 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanen
US7319154B2 (en) * 2005-07-21 2008-01-15 Bayer Schering Pharma Ag Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes
US20080032147A1 (en) * 2005-08-26 2008-02-07 Thomas Neel Medium density fibreboard

Also Published As

Publication number Publication date
ES2311927T5 (es) 2014-09-08
PL1746101T3 (pl) 2009-01-30
ATE403668T1 (de) 2008-08-15
AR055993A1 (es) 2007-09-12
PL1746101T5 (pl) 2014-11-28
ES2311927T3 (es) 2009-02-16
US20070049747A1 (en) 2007-03-01
CN101223186A (zh) 2008-07-16
UY29686A1 (es) 2007-02-28
DOP2006000172A (es) 2007-02-15
EP1746101A1 (de) 2007-01-24
ZA200801674B (en) 2009-08-26
GT200600321A (es) 2007-02-23
SI1746101T1 (sl) 2009-02-28
EP1746101B1 (de) 2008-08-06
SV2007002621A (es) 2007-12-12
PE20131303A1 (es) 2013-11-27
UA100092C2 (en) 2012-11-12
CN101223186B (zh) 2012-09-05
JP5345843B2 (ja) 2013-11-20
TW200716660A (en) 2007-05-01
TWI392683B (zh) 2013-04-11
DE502005004948D1 (de) 2008-09-18
CY1110411T1 (el) 2015-04-29
US20110275796A1 (en) 2011-11-10
JP2009501753A (ja) 2009-01-22
US8658788B2 (en) 2014-02-25
JP2013177450A (ja) 2013-09-09
MY147795A (en) 2013-01-31
PE20070215A1 (es) 2007-04-11
SI1746101T2 (sl) 2014-09-30
DK1746101T3 (da) 2008-11-24
PT1746101E (pt) 2008-10-27
EP1746101B2 (de) 2014-05-14

Similar Documents

Publication Publication Date Title
DK1746101T4 (da) Fremgangsmåde til fremstilling af 3-oxo-pregn-4-en-21,17-carbolactoner ved metalfri oxidation af 17-(3-hydroxypropyl)-3,17-dihydroxyandrostaner
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK2046767T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK1945271T3 (da) Fremgangsmåde til fremstilling af polymerbelagte mikropartikler
CL2008000322A1 (es) Proceso para la preparacion de un compuesto derivado de 2-tiazol-2-il-quinolina; compuestos intermediarios; y proceso de preparacion de dichos compuestos intermediarios.
DK1863833T3 (da) Fremgangsmåde til fremstilling af makrocykliske forbindelser
DK1852430T3 (da) Fremgangsmåde til fremstilling af proanthocyanidinoligomer
DK1856024T3 (da) Fremgangsmåde til fremstilling af substituerede biphenyler
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1885337T3 (da) Lægemiddel, især kræfthæmmende middel, til behandling ved hjælp af immunterapi, især autolog
DK1846376T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid
DK1843977T3 (da) Fremgangsmåde til fremstilling af cæsiumhydroxidopløsninger
CL2007002727A1 (es) Proceso de preparacion de anastrozol; y compuestos intermediarios.
IL188619A (en) Process for Preparation of 3-Oxo-Pargen-4-Ann-21, 17-Carbolactones by Non-Metal Oxidation of 17- (3-Hydroxypropyl) -17,3-Dihydroxyandrostanes
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1805316T3 (da) Fremgangsmåde til fremstilling af de enantiomere former af cis-3-hydroxycy-
DK1866297T3 (da) Fremgangsmåde til fremstilling af en aminomethyl-thiazolforbindelse
DK1912961T3 (da) Fremgangsmåde til fremstilling af bepromolin
DK1756075T3 (da) Forbindelse til fremstilling af thiazol ved aminomethylering
DK1931618T3 (da) Fremgangsmåde til fremstilling af aniliner
DK1937662T3 (da) Fremgangsmåde til fremstilling af duloxetin
DK1727792T3 (da) Fremgangsmåde til fremstilling af semicarbazoner